CrossrefInfokarte
Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies
Oncotarget · 2025-05-09 · 16 (1) · 329-336
DOI: 10.18632/oncotarget.28719 ↗Abstract
Kein Abstract verfügbar.
EUVIMED